1. Home
  2. IPA vs CLYM Comparison

IPA vs CLYM Comparison

Compare IPA & CLYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPA
  • CLYM
  • Stock Information
  • Founded
  • IPA 1983
  • CLYM 2018
  • Country
  • IPA United States
  • CLYM United States
  • Employees
  • IPA N/A
  • CLYM N/A
  • Industry
  • IPA Biotechnology: Pharmaceutical Preparations
  • CLYM
  • Sector
  • IPA Health Care
  • CLYM
  • Exchange
  • IPA Nasdaq
  • CLYM NYSE
  • Market Cap
  • IPA 74.6M
  • CLYM 83.8M
  • IPO Year
  • IPA 2017
  • CLYM 2021
  • Fundamental
  • Price
  • IPA $2.16
  • CLYM $1.45
  • Analyst Decision
  • IPA Strong Buy
  • CLYM Buy
  • Analyst Count
  • IPA 2
  • CLYM 1
  • Target Price
  • IPA $4.00
  • CLYM $10.00
  • AVG Volume (30 Days)
  • IPA 2.1M
  • CLYM 357.1K
  • Earning Date
  • IPA 09-15-2025
  • CLYM 08-13-2025
  • Dividend Yield
  • IPA N/A
  • CLYM N/A
  • EPS Growth
  • IPA N/A
  • CLYM N/A
  • EPS
  • IPA N/A
  • CLYM N/A
  • Revenue
  • IPA $16,581,105.00
  • CLYM N/A
  • Revenue This Year
  • IPA $4.67
  • CLYM N/A
  • Revenue Next Year
  • IPA $14.15
  • CLYM N/A
  • P/E Ratio
  • IPA N/A
  • CLYM N/A
  • Revenue Growth
  • IPA 1.34
  • CLYM N/A
  • 52 Week Low
  • IPA $0.27
  • CLYM $1.05
  • 52 Week High
  • IPA $2.41
  • CLYM $9.05
  • Technical
  • Relative Strength Index (RSI)
  • IPA 66.79
  • CLYM N/A
  • Support Level
  • IPA $1.61
  • CLYM N/A
  • Resistance Level
  • IPA $1.85
  • CLYM N/A
  • Average True Range (ATR)
  • IPA 0.30
  • CLYM 0.00
  • MACD
  • IPA 0.02
  • CLYM 0.00
  • Stochastic Oscillator
  • IPA 73.68
  • CLYM 0.00

About IPA ImmunoPrecise Antibodies Ltd.

ImmunoPrecise Antibodies Ltd is a techbio company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. IPA has several subsidiaries in North America and Europe.

About CLYM CLIMB BIO INC

Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.

Share on Social Networks: